NadN and e (P4) are essential for utilization of NAD and nicotinamide mononucleotide but not nicotinamide riboside in Haemophilus influenzae.
Haemophilus influenzae has an absolute requirement for NAD (factor V) because it lacks almost all the biosynthetic enzymes necessary for the de novo synthesis of that cofactor. Factor V can be provided as either nicotinamide adenosine dinucleotide (NAD), nicotinamide mononucleotide (NMN), or nicotinamide riboside (NR) in vitro, but little is known about the source or the mechanism of uptake of these substrates in vivo. As shown by us earlier, at least two gene products are involved in the uptake of NAD, the outer membrane lipoprotein e (P4), which has phosphatase activity and is encoded by hel, and a periplasmic NAD nucleotidase, encoded by nadN. It has also been observed that the latter gene product is essential for H. influenzae growth on media supplemented with NAD. In this report, we describe the functions and substrates of these two proteins as they act together in an NAD utilization pathway. Data are provided which indicate that NadN harbors not only NAD pyrophosphatase but also NMN 5'-nucleotidase activity. The e (P4) protein is also shown to have NMN 5'-nucleotidase activity, recognizing NMN as a substrate and releasing NR as its product. Insertion mutants of nadN or deletion and site-directed mutants of hel had attenuated growth and a reduced uptake phenotype when NMN served as substrate. A hel and nadN double mutant was only able to grow in the presence of NR, whereas no uptake of NMN was observed.
Kemmer
G
G
Zentrum für Infektionsforschung, Universität Würzburg, 97070 Würzburg, Germany.
Reilly
T J
TJ
Schmidt-Brauns
J
J
Zlotnik
G W
GW
Green
B A
BA
Fiske
M J
MJ
Herbert
M
M
Kraiss
A
A
Schlör
S
S
Smith
A
A
Reidl
J
J
D001425:Bacterial Outer Membrane Proteins / Q000378:metabolism*; D001426:Bacterial Proteins; D001692:Biological Transport; D004950:Esterases; D006193:Haemophilus influenzae / Q000378:metabolism*; D008074:Lipoproteins / Q000378:metabolism*; D008954:Models, Biological; D009097:Multienzyme Complexes / Q000235:genetics / Q000378:metabolism*; D009243:NAD / Q000378:metabolism*; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000378:metabolism*; D009537:Nicotinamide Mononucleotide / Q000378:metabolism*; D009708:Nucleotidases / Q000235:genetics / Q000378:metabolism*; D011726:Pyridinium Compounds; D011755:Pyrophosphatases / Q000235:genetics / Q000378:metabolism*
D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D008074:Lipoproteins; D009097:Multienzyme Complexes; D011726:Pyridinium Compounds; C098614:e(P4) lipoprotein, Haemophilus influenzae; C018613:nicotinamide-beta-riboside; D009243:NAD; D009537:Nicotinamide Mononucleotide; D009536:Niacinamide; D004950:Esterases; D009708:Nucleotidases; C430338:NadN protein, Haemophilus influenzae; D011755:Pyrophosphatases